In cancer research, there has been a tendency to differentiate between the genes responsible for tumour development and those that give rise to metastasis and to study these processes separately si
Research Programmes / Core Facilities
Cell and Developmental Biology
Structural and Computational Biology
Chemistry and Molecular Pharmacology
Core Facilities & Services
Scientists at IRB Barcelona are supported by an extensive range of common core facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible.
IRB Barcelona's partnerships, with organisations in areas of mutual interest and expertise, aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine
Selected IRB Barcelona publications
News & Events
Genes activated in metastasis also drive the first stages of tumour growth
Ernest Giralt: "There are many diseases caused by failures in the protein-protein interactions”
IRB Barcelona paves the way to the use of immunotherapy to treat aggressive colon tumours and their metastasis
Understanding the adaptability of Smads
21FebGene coexpression domains in the human genome
22FebOrigins of metastasis – are unfaithful enhancers to blame?
23FebLife-saving regeneration of the entire human epidermis by transgenic stem cells
28FebScience Writing Training
The chemist Ernest Giralt (Viladecans, 1948) is the head of the Peptides a
In a short space of time, immunotherapy, that is to say therapies based on stimulating the immune system against cancer cells, has become a powerful approach to treat cancers such as melanoma and l
The main TGF-β signal transduction mechanism is the Smad pathway. As transcription factors, Smad proteins interact directly with DNA.